Related Experiment Video
Updated: Jul 16, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a
Mohit Khera1, Anthony Bella2, Edward Karpman3
1Baylor College of Medicine, Houston, TX, USA.
Inflatable penile prosthesis (IPP) placement is safe and effective for men with erectile dysfunction and Peyronie's disease (PD). Patient satisfaction and device usage remain high, with a notable decrease in depressive symptoms post-implantation.
Area of Science:
- Urology
- Andrology
- Sexual Medicine
Background:
- Erectile dysfunction (ED) frequently coexists with Peyronie's disease (PD).
- Limited data exist on the efficacy and patient satisfaction with inflatable penile prosthesis (IPP) in men with both conditions.
Purpose of the Study:
- To evaluate the efficacy and patient satisfaction of IPP implantation in men with ED and concurrent PD.
- To analyze outcomes from the Prospective Registry of Outcomes with Penile Prosthesis for Erectile Restoration (PROPPER) study.
Main Methods:
- Data from 250 patients with PD undergoing IPP placement were analyzed from the PROPPER study.
- Patient characteristics, implant details, operative times, and validated questionnaire data up to 2 years were collected.
- Surgical outcomes were compared to patients without PD.
Main Results:
- IPP placement in PD patients showed comparable surgical times and outcomes to non-PD patients.
- Over 80% of PD patients reported satisfaction, and over 88% used their device at 1- and 2-year follow-ups.
- Pre-operative depressive symptoms decreased significantly at 1- and 2-year follow-ups (19.3% to ~10.5%).
Conclusions:
- IPP implantation is a safe and effective treatment for men with ED and PD.
- Patients experience high satisfaction and device usage rates.
- IPP placement may lead to a reduction in depressive symptoms for patients with PD.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

